Overview of Peptic Ulcer Disease: Epidemiology, Causes, Pathophysiology, and Clinical Importance

Peptic Ulcer Disease (PUD) is a prevalent gastrointestinal condition characterized by ulcerative lesions in the stomach, duodenum, or lower esophagus, resulting from an imbalance between aggressive factors such as gastric acid, pepsin, Helicobacter pylori infection, and NSAID use, and protective mechanisms including mucus and bicarbonate secretion. Affecting approximately 5–14% of the global population—primarily men aged 40 to 60—PUD presents with symptoms like epigastric pain and discomfort, with diagnosis often confirmed via upper gastrointestinal endoscopy. The pathophysiology of PUD involves complex interactions among genetic predisposition, environmental triggers, and lifestyle factors. Its chronic nature, characterized by alternating periods of flare-ups and remission, poses significant clinical and economic challenges. Advances in understanding gastric physiology and the identification of H. pylori have transformed the management and surgical approach to the disease, underscoring its continued relevance in modern gastroenterology.

Authors

Institutions

Publication Details

Journal
Current Pharmaceutical Research
Published
2025-06-20
DOI
https://doi.org/10.63785/cpr.2025.1.2.184192
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Overview of Peptic Ulcer Disease: Epidemiology, Causes, Pathophysiology, and Clinical Importance

Tawqeer Shafi, Sukhwinder Singh, Shivani Malik, Gursewak Singh
Current Pharmaceutical Research
Helicobacter pylori-related gastroenterology studies
article

Overview of Peptic Ulcer Disease: Epidemiology, Causes, Pathophysiology, and Clinical Importance

Tawqeer Shafi, Sukhwinder Singh, Shivani Malik, Gursewak Singh
article en

Abstract

Peptic Ulcer Disease (PUD) is a prevalent gastrointestinal condition characterized by ulcerative lesions in the stomach, duodenum, or lower esophagus, resulting from an imbalance between aggressive factors such as gastric acid, pepsin, Helicobacter pylori infection, and NSAID use, and protective mechanisms including mucus and bicarbonate secretion. Affecting approximately 5–14% of the global population—primarily men aged 40 to 60—PUD presents with symptoms like epigastric pain and discomfort, with diagnosis often confirmed via upper gastrointestinal endoscopy. The pathophysiology of PUD involves complex interactions among genetic predisposition, environmental triggers, and lifestyle factors. Its chronic nature, characterized by alternating periods of flare-ups and remission, poses significant clinical and economic challenges. Advances in understanding gastric physiology and the identification of H. pylori have transformed the management and surgical approach to the disease, underscoring its continued relevance in modern gastroenterology.

Current Pharmaceutical Research
Desh Bhagat University (IN)
Good health and well-being
Openalex Percentile: Top 67%
Helicobacter pylori-related gastroenterology studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.